Drugs / Phytomenadione
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial · 1 missed | ||||||
| — | NCT04247087 | Sep 2017 → Sep 2019 | calcinosis | Mexican Social Security Institute | Completed | Missed primary |
| Comparator or background therapy1 trial | ||||||
| — | NCT03547895 Comparator | Jun 2015 → May 2016 | cirrhosis of liver | Zagazig University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Phytomenadione | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03547895 ↗ |
| Known as | vitamin K | “vitamin K (Phytomenadione) 10 mg+ furosemide and spironolactone (Lasilactone) 50 mg + milk thistle (Silymarin) 140 mg + Albumin infusion” NCT03547895 ↗ |